HER3 in cancer: from the bench to the bedside
Abstract The HER3 protein, that belongs to the ErbB/HER receptor tyrosine kinase (RTK) family, is expressed in several types of tumors. That fact, together with the role of HER3 in promoting cell proliferation, implicate that targeting HER3 may have therapeutic relevance. Furthermore, expression and...
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
BMC
2022-10-01
|
| Σειρά: | Journal of Experimental & Clinical Cancer Research |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s13046-022-02515-x |